Parkinson's treatment could go monthly: new injection tested
Disease control
Ongoing
This early-stage study tests a new long-acting injection called HNC364, which turns into the Parkinson's drug rasagiline in the body. Researchers want to see how much of the drug gets into the bloodstream compared to taking rasagiline pills daily. The study involves 30 healthy ad…
Phase: PHASE1 • Sponsor: Guangzhou Henovcom Bioscience Co. Ltd. • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC